According to Amneal Pharmaceuticals
's latest financial reports the company has a price-to-book ratio of 90.5.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Year | P/B ratio | Change |
---|---|---|
2023-12-31 | 93.0 | 2731.63% |
2022-12-31 | 3.28 | 68.43% |
2021-12-31 | 1.95 | -0.32% |
2020-12-31 | 1.96 | -52.96% |
2019-12-31 | 4.16 | -7.75% |
2018-12-31 | 4.51 | |
2017-12-31 | N/A |
Company | P/B ratio | differencediff. | Country |
---|---|---|---|
OPKO Health
OPK | 0.6322 | -99.30% | ๐บ๐ธ USA |
Onconova Therapeutics ONTX | 1.44 | -98.41% | ๐บ๐ธ USA |